Insider Selling: Atossa Genetics CEO Sells 7,265 Shares of Stock (ATOS)
Atossa Genetics (NASDAQ:ATOS) CEO Steven Quay sold 7,265 shares of the company’s stock on the open market in a transaction that occurred on Tuesday, October 1st. The stock was sold at an average price of $5.66, for a total value of $41,119.90. Following the sale, the chief executive officer now directly owns 584,543 shares of the company’s stock, valued at approximately $3,308,513. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.
Shares of Atossa Genetics (NASDAQ:ATOS) traded up 0.19% during mid-day trading on Friday, hitting $5.32. 414,177 shares of the company’s stock traded hands. Atossa Genetics has a 52-week low of $3.44 and a 52-week high of $12.40. The stock’s 50-day moving average is $5.00 and its 200-day moving average is $5.85. The company’s market cap is $82.9 million.
Atossa Genetics (NASDAQ:ATOS) last issued its quarterly earnings data on Wednesday, August 14th. The company reported ($0.17) EPS for the quarter. The company had revenue of $0.33 million for the quarter, compared to the consensus estimate of $0.28 million. On average, analysts predict that Atossa Genetics will post $-0.55 earnings per share for the current fiscal year.
Atossa Genetics Inc is a development-stage healthcare company focused on the prevention of breast cancer through the commercialization of diagnostic tests that can detect precursors to breast cancer, and through the research, development, and ultimate commercialization of treatments for pre-cancerous lesions.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.